Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

23847studies shown

Showing 23,113-23,124 of 23,847

Drug study icon

CompletedNCT00083668

Study Evaluating Three Fixed Doses of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of people with Schizophrenia

This study is completed. It focuses on schizophrenia.

Location not clearly listed

SchizophreniaDrugFrom 18 Years to 65 Years

Countries
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition: Schizophrenia

Behavioral study icon

CompletedNCT04779099

study of a Brief Psychological Intervention for Suicidal people with Borderline Personality Disorder in the Emergency Department

This summary needs review. Please check the official study record and contact the research team for details.

In Toronto

SuicidalityBehavioralOver 16 Years

Countries: Canada
Sponsor: Centre for Addiction and Mental Health
Condition: Suicidality

Behavioral study icon

CompletedNCT02803567

study of a Novel Brief Intervention on Health Behaviors for Youth With Chronic Medical Conditions

This summary needs review. Please check the official study record and contact the research team for details.

In Boston

AddictionBehavioralFrom 14 Years to 17 Years

Countries: United States
Sponsor: Boston Children's Hospital
Condition: Addiction

Behavioral study icon

CompletedNCT02461732

study of a Novel Cognitive-Behavioral Treatment for Posttraumatic Stress and Substance Dependence

This summary needs review. Please check the official study record and contact the research team for details.

In Houston

PTSDBehavioralFrom 18 Years to 65 Years

Countries: United States
Sponsor: The University of Texas Health Science Center, Houston
Condition: PTSD

Behavioral study icon

CompletedNCT02004145

study of a Positive Psychology Intervention in Major Depressive Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In Boston

DepressionBehavioralOver 18 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: Depression

Drug study icon

CompletedNCT00235352

study of Ampakine Added to Clozapine, Olanzapine or Risperidone in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Boston

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: North Suffolk Mental Health Association
Condition: Schizophrenia

Drug study icon

CompletedNCT01663532

study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Little Rock

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States, Croatia, Latvia
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Schizophrenia

Behavioral study icon

TerminatedNCT02610049

study of Art Therapy During Cognitive Processing Therapy for PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In Hampton

PTSDBehavioralOver 18 Years

Countries: United States
Sponsor: Hampton VA Medical Center
Condition: PTSD

Behavioral study icon

CompletedNCT00505440

study of Automated Risk Appraisal for Adolescents

This summary needs review. Please check the official study record and contact the research team for details.

In Columbus

Suicidality, Addiction, ...BehavioralFrom 11 Years to 20 Years

Countries: United States
Sponsor: Nationwide Children's Hospital
Condition: Suicidality, Addiction, ...

Drug study icon

CompletedNCT05536414

Study of Centanafadine Efficacy and Safety as Monotherapy or as Adjunct to SSRI in Adults With Major Depressive Disorder

This study is completed in the United States. It focuses on depression.

Multiple locations, including Yuma

DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Depression

Behavioral study icon

WithdrawnNCT01784653

study of Computerized MET for Adolescent Substance Use

This summary needs review. Please check the official study record and contact the research team for details.

In Boston

AddictionBehavioralFrom 12 Years to 21 Years

Countries: United States
Sponsor: Boston Children's Hospital
Condition: Addiction

Behavioral study icon

WithdrawnNCT01784627

study of Computerized SBI to Reduce Teen Alcohol Use

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Boston

AddictionBehavioralFrom 9 Years to 20 Years

Countries: United States
Sponsor: Boston Children's Hospital
Condition: Addiction

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.